Edition:
United States

NanoCarrier Co Ltd (4571.T)

4571.T on Tokyo Stock Exchange

881JPY
20 Jan 2017
Change (% chg)

¥-3 (-0.34%)
Prev Close
¥884
Open
¥884
Day's High
¥886
Day's Low
¥872
Volume
179,000
Avg. Vol
359,491
52-wk High
¥2,095
52-wk Low
¥760

4571.T

Chart for 4571.T

About

NanoCarrier Co., Ltd. is a Japan-based biopharmaceutical products developer. The Company develops biopharmaceutical products focused on the medication of cancer and other intractable diseases. It is engaged in the research, development, manufacture, and sale of anti-cancer drugs based on micellar nanoparticle technology. The... (more)

Overall

Beta: 2.12
Market Cap(Mil.): ¥38,166.16
Shares Outstanding(Mil.): 43.17
Dividend: --
Yield (%): --

Financials

  4571.T Industry Sector
P/E (TTM): -- 44.51 30.50
EPS (TTM): -79.44 -- --
ROI: -25.10 -1.38 14.85
ROE: -27.68 -1.00 16.27

BRIEF-NanoCarrier gets substance patent grant in EU

* Says it received substance patent grant from European Patent Office

Jan 11 2017

BRIEF-NanoCarrier cancels cancer medicine licensing and joint development contract with Kowa Company Ltd

* Says the co canceled the licensing for a cancer medicine NC-6300(K-912) and joint development cooperation contract with Kowa Company Ltd, which was signed on Sep. 26. 2011

Oct 21 2016

BRIEF-NanoCarrier affirms safety profile and efficacy of NC-6004 in Phase Ib clinical study in US

* Says it confirmed safety profile and efficacy of NC-6004 in the Phase Ib clinical study conducted in the U.S.

Oct 11 2016

BRIEF-Bind Therapeutics determines Pfizer's $40 mln bid highest

* Plans to disclose additional terms of its agreement with Pfizer upon court approval.

Jul 26 2016

Earnings vs. Estimates